Salt of tetrahydrotriazolopyridine derivative and crystal thereof
    1.
    发明授权
    Salt of tetrahydrotriazolopyridine derivative and crystal thereof 有权
    四氢三唑并吡啶衍生物的盐及其结晶

    公开(公告)号:US08703954B2

    公开(公告)日:2014-04-22

    申请号:US13143130

    申请日:2010-02-24

    CPC classification number: C07D471/04

    Abstract: The present invention provides a crystal of a 1.5 D-tartrate of a compound represented by the formula (1) having an A production inhibitory effect, characterized in that the crystal has a diffraction peak at a diffraction angle (20.2) of 23.2 in powder X-ray diffractometry; a crystal of a disulfate of the compound of the formula (1), characterized in that the crystal has a diffraction peak at a diffraction angle (20.2) of 17.1 in powder X-ray diffractometry; various other salts of the compound of the formula (1); crystal polymorphs of these salts; and the like, which are expected to be used as drug substances.

    Abstract translation: 本发明提供具有A生成抑制作用的式(1)表示的化合物的1.5酒石酸盐的晶体,其特征在于,所述晶体在粉末X中的衍射角(20.2)为23.2°的衍射峰 射线衍射; 式(1)化合物的二硫酸盐的结晶,其特征在于,在粉末X射线衍射中,晶体具有衍射角(20.2)为17.1°的衍射峰; 式(1)化合物的各种其它盐; 这些盐的晶体多晶型物; 等等,其预期用作药物物质。

    SALT OF TETRAHYDROTRIAZOLOPYRIDINE DERIVATIVE AND CRYSTAL THEREOF
    2.
    发明申请
    SALT OF TETRAHYDROTRIAZOLOPYRIDINE DERIVATIVE AND CRYSTAL THEREOF 有权
    四氢呋喃并吡啶衍生物及其结晶的盐

    公开(公告)号:US20110275822A1

    公开(公告)日:2011-11-10

    申请号:US13143130

    申请日:2010-02-24

    CPC classification number: C07D471/04

    Abstract: The present invention provides a crystal of a 1.5 D-tartrate of a compound represented by the formula (1) having an A production inhibitory effect, characterized in that the crystal has a diffraction peak at a diffraction angle (20.2) of 23.2 in powder X-ray diffractometry; a crystal of a disulfate of the compound of the formula (1), characterized in that the crystal has a diffraction peak at a diffraction angle (20.2) of 17.1 in powder X-ray diffractometry; various other salts of the compound of the formula (1); crystal polymorphs of these salts; and the like, which are expected to be used as drug substances.

    Abstract translation: 本发明提供具有A生成抑制效果的式(1)表示的化合物的1.5酒石酸盐的晶体,其特征在于,所述晶体在粉末X中的衍射角(20.2°)为23.2°的衍射峰 射线衍射; 式(1)化合物的二硫酸盐的结晶,其特征在于,在粉末X射线衍射中,晶体具有衍射角(20.2)为17.1°的衍射峰; 式(1)化合物的各种其它盐; 这些盐的晶体多晶型物; 等等,其预期用作药物物质。

Patent Agency Ranking